Centene (NYSE:CNC) FY Conference Summary Company Overview - **Company**: Centene Corporation - **Event**: Barclays Global Healthcare Conference - **Date**: March 10, 2026 Key Points Current Business Performance - Centene reaffirms adjusted EPS guidance of greater than $3 for 2026, with all three core business lines (Medicaid, Medicare, and Marketplace) on track so far [4][8] - Medicaid membership is expected to be approximately 3.5 million by the end of Q1 2026, down from 5.5 million in December 2025 [5][10] - The company is optimistic about the execution of ongoing trend initiatives impacting Medicaid and Medicare [4][8] Marketplace Dynamics - Membership in the Marketplace has decreased from 5.5 million in December to 3.6 million in February 2026, with expectations of reaching around 3.5 million by the end of the quarter [5][10] - The distribution of metal tiers shows a shift, with mid-30s% in Bronze, high teens% in Gold, and just under 50% in Silver [6][11] - Higher utilization patterns in specialty pharmacy are noted, particularly in the Silver tier, which may impact risk adjustment calculations [6][17] Risk Adjustment and Data Insights - Centene is tracking a Wakely report due at the end of March, which will provide insights into market contraction and membership distribution across metal tiers [7][13] - The company anticipates being in a net payable position for risk adjustment in 2026, but will remain conservative until full data is available [13][16] - The focus is on understanding therapeutic classes and disease states to inform risk adjustment strategies [17][18] Medicaid Trends and Initiatives - Medicaid cost trend for 2026 is expected to be around 4.5%, down from mid-6% in 2025 [19][20] - Centene is actively working on initiatives to combat fraud, waste, and abuse, which is estimated to account for 10% of all healthcare spending [22][23] - The company has developed 75 algorithms to identify suspect claims and is enhancing data sharing with state partners to improve program integrity [22][25] Medicare and Part D Insights - The individual PDP industry growth is expected to accelerate from 1% in 2025 to close to 3% in 2026, with Centene taking market share [31] - The company aims for a Part D margin of around 2% for 2026, with a focus on maintaining a favorable cost structure [32][33] - Medicare Advantage margins are projected to be slightly below break-even in 2026, with a goal of achieving break-even by 2027 [35][36] Capital Deployment Strategy - Centene plans no share repurchase in 2026, focusing instead on a partial redemption of $1 billion of 2027 notes to recalibrate debt levels [39][40] - The company is exploring ways to generate cash and monetize assets as part of its capital deployment strategy [40] Future Outlook on Medicaid Policy - Membership levels in Medicaid are expected to decline slightly due to tighter eligibility verification processes [41][42] - The impact of OB3 and work requirements will be assessed on a state-by-state basis, with guidance from CMS expected to influence future membership and margins [44][46] Additional Insights - The dialogue with CMS regarding Medicare rates has focused on ensuring that trend assumptions are reflective of current realities, particularly in light of COVID-19 data [36][37] - Centene is preparing for potential shifts in risk pools due to changes in Medicaid rates and eligibility requirements [46] This summary encapsulates the key insights and strategic directions discussed during the conference, highlighting Centene's performance, market dynamics, and future outlook in the healthcare sector.

Core Insights - The article discusses the considerations for an individual contemplating divorce at the age of 62, particularly focusing on financial planning and legal implications [3][4]. Financial Planning - The individual has $1.5 million in investments and no home ownership, which necessitates a detailed financial plan before proceeding with divorce [4][6]. - A recommended annual withdrawal rate from investments is 3%-4%, translating to $45,000 to $60,000 per year, or approximately $3,750 to $5,000 per month before tax [6]. Legal Considerations - The length of the marriage and the state of residence (community-property vs. equitable-distribution) will significantly impact the division of assets [5]. - In community-property states, marital assets are owned equally, meaning a spouse could be entitled to half of the other’s earnings during the marriage [5]. Health Insurance - Health insurance is a critical factor, especially since the individual does not qualify for Medicare until age 65. Divorce may trigger special enrollment opportunities for health insurance [7]. - Options for health insurance post-divorce include COBRA, ACA Marketplace, or Medicaid, with potential costs exceeding $500 per month for ACA [7].

Medicaid data has been open sourced, so the level of fraud is easy to identify.@DOGE is not a department, it’s a state of mind.DOGE HHS (@DOGE_HHS):Today the HHS DOGE team open sourced the largest Medicaid dataset in department history.This dataset contains aggregated, provider-level claims data for a specific billing code over time.For example, using this dataset, it would have been possible to easily detect the ...

Financial Data and Key Metrics Changes - The company reported adjusted EPS of $17.14 for 2025, exceeding initial guidance of approximately $16.25 [17] - The full-year insurance segment benefit ratio was 90.4%, slightly better than guidance [18] - For 2026, the company expects full-year adjusted EPS of at least $9, with a year-over-year decline anticipated due to a stars headwind [19] Business Line Data and Key Metrics Changes - The company experienced approximately 1 million member growth, or 20%, during the Annual Enrollment Period (AEP) [8] - Retention rate improved by over 500 basis points year-over-year, with over 70% of new sales coming from switches from competitor plans [9] - The company expects individual Medicare Advantage (MA) membership growth of approximately 25% for full year 2026 [10] Market Data and Key Metrics Changes - The company absorbed approximately 12% of members impacted by competitor plan exits, which is less than its market share [9] - Nearly 30% of new sales were bounce-back members, indicating a positive mix of new sales [9] Company Strategy and Development Direction - The company remains committed to a consumer-centric strategy, focusing on maximizing customer lifetime value and member retention [6] - Plans are designed to be priced for sustainable margins, moving away from loss leader strategies [8] - The company is expanding its Medicaid and CenterWell footprint, with Medicaid now spanning 13 states [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational capacity to absorb growth and maintain quality care for members [10] - The company is adapting to the funding environment and expects to unlock earnings potential by 2028 [15] - Management acknowledged the challenges posed by the Advance Rate Notice but emphasized a commitment to protect consumers [15] Other Important Information - The company is focused on capital efficiency and plans to fund membership growth and strategic acquisitions while maintaining credit ratings [24] - A new President of Medicare Advantage, Aaron Martin, joined the company, bringing extensive healthcare experience [16] Q&A Session Summary Question: Can you expand on the level of earnings outside of MA underwriting? - Management indicated that earnings associated with CenterWell will contribute positively, with significant tailwinds expected from new membership [30] Question: How is the typical progress of margins for new members over time? - Management noted that margins typically improve significantly from year one to year two, with ongoing improvements expected in subsequent years [35] Question: What are the expectations for 2026 compared to Investor Day? - Management highlighted that the biggest difference is the embedded conservatism in their numbers, leading to a broader haircut in guidance [45] Question: How did the D-SNP membership growth compare to expectations? - The absolute number of new D-SNP members exceeded expectations, although the percentage growth was slightly lower [48] Question: What is the impact of the stars headwind on margins? - Management explained that the stars headwind affects both new and existing members, with similar margins expected for both cohorts [32] Question: How will the company adjust to the rate notice? - Management stated that they will adapt to the final rate notice and advocate for appropriate funding levels [59]

Core Insights - The first year of retirement is a critical financial transition that requires careful management of income, taxes, budgeting, and long-term planning [1][2] Group 1: Essential Money Moves - Tracking expenses is crucial in the first months of retirement to understand spending patterns and adjust budgets accordingly [3] - Securing healthcare coverage is essential, especially for those not yet eligible for Medicare, to avoid depleting savings due to unexpected medical costs [4][5] - Proper allocation of retirement funds is necessary to align with risk tolerance and time frame, balancing between less risky assets and stocks for long-term growth [6][7][8]

Core Viewpoint - Centene expects a rebound in 2026 with adjusted EPS greater than $3, implying over 40% year-over-year growth, driven by Medicaid margin stability, significant margin recovery in Marketplace, and continued improvement toward Medicare Advantage break-even by 2027 [1][4][7] Medicaid - Centene reported a fourth-quarter health benefits ratio (HBR) of 93.0%, showing a 40 basis points sequential improvement and 190 basis points improvement from Q2 levels [8] - The company anticipates a mid-4% net rate impact and mid-4% net trend for 2026, while expecting ongoing Medicaid membership attrition, closing 2025 at 12.5 million members [11][12] - Management is focused on restoring sustainable profitability in Medicaid through operational levers such as network optimization and clinical programs [9] Marketplace - The Marketplace segment is expected to face a smaller membership base due to the expiration of Enhanced Advance Premium Tax Credits (EAPTC), with Ambetter membership projected at approximately 3.5 million by Q1 2026, down from 5.5 million in December [5][15] - Centene anticipates Marketplace pre-tax margins to recover to around 4% in 2026, compared to a loss of approximately 1% in 2025 [17] - The company has accounted for estimated 2026 No Surprises Act costs in its guidance and is advocating for reform [14] Medicare - Centene's Medicare segment is expected to grow premium revenue by about $7.5 billion, with membership projected at approximately 8.7 million coming out of open enrollment [20] - The company aims for break-even results in Medicare Advantage by 2027, with dual-eligible members making up roughly 40% of its Medicare Advantage business [19] - The direct subsidy for Part D increased from $143 to $200, which is expected to raise the HBR without requiring higher SG&A [21] Financial Guidance - For 2026, Centene guided premium and service revenue between $170 billion and $174 billion, with a consolidated HBR of 90.9% to 91.7% [23][24] - The company expects the majority of 2026 adjusted EPS to occur in Q1, with a step-down through the year and a loss anticipated in Q4 [26] - Centene ended 2025 with approximately $400 million in cash for corporate use and reduced debt by $189 million in Q4, reporting a debt-to-cap ratio of 46.5% [25]

Core Insights - Centene Corporation (CNC) reported a fourth-quarter 2025 adjusted loss per share of $1.19, which was better than the Zacks Consensus Estimate of a loss of $1.25 per share, compared to adjusted earnings of 80 cents per share in the same quarter last year [1][9] - Total revenues reached $49.7 billion, reflecting a year-over-year increase of 21.9% and surpassing the consensus estimate by 3.1% [1][4] Revenue Breakdown - Medicaid revenues increased by 11% year over year to $23 billion, while Medicare revenues surged 75% year over year to $9.6 billion. Commercial revenues rose 24% year over year to $10.8 billion [3] - Premium revenues grew by 23.8% year over year to $44 billion, driven by higher premiums and membership in the PDP and Marketplace businesses, as well as Medicaid rate hikes, exceeding the Zacks Consensus Estimate of $43.5 billion [4] Membership and Costs - Total membership declined by 3.4% year over year to 27.6 million, missing the consensus mark of 27.9 million, primarily due to decreases in Medicaid and Medicare memberships [5] - The health benefits ratio worsened by 470 basis points year over year to 94.3%, with operating expenses rising 26.7% year over year to $51.5 billion, largely due to increased medical costs, which escalated by 30.4% year over year [6][9] Financial Position - As of December 31, 2025, Centene had cash and cash equivalents of $17.9 billion, a 27.2% increase from the end of 2024. Total assets decreased by 6.9% to $76.7 billion, while long-term debt fell by 5.8% to $17.4 billion [7] - The company generated $5.1 billion in net cash from operations in 2025, a significant increase from the previous year [8] Full-Year Performance - For the full year 2025, total revenues amounted to $194.8 billion, a 19.4% increase from 2024, while adjusted EPS dropped 71% year over year to $2.08. Premium and service revenues reached $174.6 billion, up 20% year over year [11] 2026 Guidance - Management projects premium and service revenues for 2026 to be between $170 billion and $174 billion, indicating a potential decline of 1.5% from 2025. Total revenues are expected to range from $186.5 billion to $190.5 billion, suggesting a 3.2% decrease from 2025 [12] - Adjusted EPS is anticipated to exceed $3.00, representing a 44.2% increase from 2025, while GAAP EPS is expected to remain above $1.98 [12]

Financial Data and Key Metrics Changes - The company reported a fourth quarter adjusted diluted loss per share of $1.19, contributing to a full year 2025 adjusted diluted EPS of $2.08, which was slightly ahead of expectations outlined in the previous quarter [7][8] - The fourth quarter GAAP diluted loss per share was $2.24, including a $389 million net loss from the divestiture of the remaining Magellan business [40][41] - The company anticipates full year 2026 adjusted EPS to exceed $3, representing over 40% year-over-year growth [10] Business Line Data and Key Metrics Changes - Medicaid's health benefits ratio (HBR) improved to 93.0% in Q4, showing a 40 basis points sequential improvement and a 190 basis points improvement from Q2 levels [12][42] - The Marketplace segment's HBR was about a point higher than forecasted, with slight improvements in medical cost trends [44] - The Medicare segment delivered strong results, with expectations for membership growth in the PDP business and a focus on achieving break-even in Medicare Advantage by 2027 [28][29] Market Data and Key Metrics Changes - The company closed 2025 with approximately 12.5 million Medicaid members, with expectations for a 5%-6% decline in member months in 2026 [43][52] - Marketplace membership is projected to be around 3.5 million by the end of Q1 2026, down from 5.5 million in December [24][53] - Medicare segment revenue is expected to grow by approximately $7.5 billion, driven by premium yield increases and membership growth [54] Company Strategy and Development Direction - The company is focused on restoring Medicaid business to sustainable profitability while enhancing quality outcomes for members [11] - Key strategies include optimizing networks, implementing new clinical programs, and increasing vigilance against fraud [13][16] - The company is leveraging data and technology, including AI, to improve operational efficiency and member engagement [34][36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in executing the 2026 outlook, citing positive momentum and opportunities for margin expansion [38] - The company acknowledged the challenges faced in 2025 but emphasized the strength gained from navigating those challenges [36] - Management highlighted the importance of proactive engagement with state partners to address rate adjustments and program reforms [100][102] Other Important Information - The company ended 2025 with approximately $400 million in cash available for corporate use and reduced debt by $189 million, resulting in a debt-to-cap ratio of 46.5% [50] - The adjusted SG&A expense ratio for Q4 was 7.5%, bringing the full year to 7.4%, reflecting continued discipline and scale [50] Q&A Session Summary Question: Medicaid rate expectation for 4.5% - Management explained that the 4.5% rate assumption is prudent, considering the favorable maturation of 2025 rates and ongoing efforts to bend trend [63][64] Question: Trend comparison for 2025 and 2026 - Management indicated that the 2025 trend was in the mid-6s, while the 2026 assumption is a net trend of mid-4s, reflecting aggressive actions taken in the latter half of 2025 [67][69] Question: Confidence in exchange member dynamics - Management expressed confidence in margin improvement for the Marketplace segment, citing improved visibility and historical data to support pricing strategies [75][84] Question: Incremental decline in Medicaid membership - Management acknowledged slight attrition in membership and discussed the impact of state eligibility tightening and program changes on future membership [86][89] Question: Actuarial soundness lookback process - Management emphasized the importance of shortening the lookback period and maximizing the inclusion of recent data in the actuarial process to inform rate adjustments [95][100] Question: Segment margins in 2026 guidance - Management provided insights into expected margins, indicating opportunities for improvement across all business lines, with specific targets for Medicaid, Marketplace, and Medicare segments [104][105]

Financial Data and Key Metrics Changes - The company reported an adjusted loss per share of $2.75 on premium revenue of $10.7 billion for Q4 2025, which was below expectations due to strong trend pressure in Medicare and Marketplace, along with retroactive items in Medicaid totaling $2 per share [6][19] - For the full year 2025, premium revenue was $43 billion, reflecting an 11% year-over-year growth, while adjusted earnings per share were $11.03, with a pretax margin of 1.6% [7][8] - The Medicaid Medical Care Ratio (MCR) for Q4 was 93.5%, and for the full year, it was 91.8% with a pretax margin of 2.8% [9][21] Business Line Data and Key Metrics Changes - In Medicaid, the MCR for Q4 was 93.5%, impacted by retroactive premium rate actions, while the adjusted MCR was 92.3% with a pretax margin of 2% [7][20] - The Medicare MCR for Q4 was 97.5%, with elevated utilization affecting margins, while the full year MCR was 92.4% [21] - The Marketplace MCR was 99% for Q4, influenced by high utilization and prior period claim settlements, with a full year MCR of 90.6% [22] Market Data and Key Metrics Changes - The company secured a historic RFP win in Florida, expected to yield $6 billion in annual run rate premium, complementing previous contract wins in Wisconsin, Georgia, and Texas, contributing over $9 billion in Medicaid premium [11] - The company anticipates 2026 premium revenue of approximately $42 billion, slightly lower than 2025, with growth from the Florida CMS contract offset by a planned reduction in the Marketplace segment [12][29] Company Strategy and Development Direction - The company aims to focus on dual-eligible members in Medicare, planning to exit the traditional MAPD product for 2027 [14] - The acquisition pipeline remains active, with the company looking to capitalize on opportunities in a challenging operating environment [12] - The company projects a low single-digit margin in Medicaid for 2026, indicating confidence in future rate restoration and earnings potential [17] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment in the 2025 results but remains confident in the long-term outlook, expecting Medicaid rates and medical cost trends to reach equilibrium [10][17] - The company believes the 2026 forecast for Medicaid represents a trough for managed Medicaid margins, with potential for recovery in subsequent years [17] - Management highlighted that every 100 basis points on the Medicaid MCR is worth nearly $5 per share, indicating significant upside potential [17] Other Important Information - The company reported a capital foundation that remains strong, with a parent company cash balance of approximately $223 million at year-end [23] - The adjusted G&A ratio for Q4 was 6.9%, reflecting disciplined cost management [22] Q&A Session Summary Question: Variance in Medicaid margins across states and potential exit considerations - Management indicated that rates are generally underfunded across the portfolio, with no current plans for exits from any states [36] Question: Adjustments to benefit design in Medicaid - Management noted some sporadic adjustments but no wholesale shifts in benefit design across states [42][48] Question: Membership attrition assumptions for 2026 - Management expects a 2% membership attrition, attributing the decline to program integrity and tightening enrollment processes [50][52] Question: Size of Medicaid expansion enrollment and attrition sources - The Medicaid expansion population is approximately 1.3 million members, with expected attrition of 15%-20% due to new work requirements [59][60] Question: Positive and negative dynamics affecting 2026 guidance - Management believes there are no significant negative dynamics, with a focus on potential upside from rate adjustments and cost trends [62][64]

Financial Data and Key Metrics Changes - The company reported an adjusted loss per share of $2.75 on $10.7 billion of premium revenue for Q4 2025, which was below expectations due to strong trend pressure in Medicare and Marketplace, along with retroactive items in Medicaid totaling $2 per share [6][19] - For the full year 2025, premium revenue was $43 billion, representing an 11% year-over-year growth, while adjusted earnings per share were $11.03, with a pretax margin of 1.6% [7][8] - The Medicaid MCR for Q4 was 93.5%, impacted by unfavorable retroactive premium rate actions, while the full year MCR was 91.8% with a pretax margin of 2.8% [7][21] Business Line Data and Key Metrics Changes - In Medicaid, the MCR for Q4 was 93.5%, and adjusting for retroactive items, it restates to 92.3% with a pretax margin of 2% [19][20] - The Medicare MCR for Q4 was 97.5%, reflecting elevated utilization of LTSS and high-cost drugs, while the full year MCR was 92.4% [21] - The Marketplace MCR for Q4 was 99%, impacted by elevated utilization and prior period claim settlements, with a full year MCR of 90.6% [22] Market Data and Key Metrics Changes - The company secured a historic RFP win in Florida, expected to yield $6 billion in annual run rate premium, complementing previous contract wins in Wisconsin, Georgia, and Texas, representing over $9 billion of Medicaid premium [10][11] - The company anticipates 2026 premium revenue of approximately $42 billion, slightly lower than 2025, driven by new contracts and planned reductions in the Marketplace segment [12][13] Company Strategy and Development Direction - The company aims to focus on dual-eligible members in Medicare, planning to exit the traditional MAPD product for 2027 [14] - The acquisition pipeline contains actionable opportunities, with the company remaining opportunistic about deploying capital for accretive acquisitions [12] - The company expects Medicaid rates and medical cost trends to eventually reach equilibrium, with a forecast for low single-digit margins in Medicaid [17][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term outlook for the business despite disappointing 2025 results, citing that the medical cost trend in 2025 was an anomaly [10][17] - The company believes that Medicaid rates are underfunded by 300-400 basis points and anticipates that actuarial soundness will prevail, allowing for target margins to be achieved [17][18] - Management expects 2026 to be a trough year for managed Medicaid margins, projecting a low single-digit margin rather than losses [17] Other Important Information - The company reported a capital foundation remains strong, with a parent company cash balance of approximately $223 million at year-end [23] - The adjusted G&A ratio for Q4 was 6.9%, reflecting disciplined cost management [22] Q&A Session Summary Question: Variance in Medicaid margins across states and potential exit considerations - Management indicated that rates are generally underfunded across the portfolio, and there are no states where an exit is being contemplated [37] - The negative retro adjustments in California were due to situational factors, including a retroactive corridor for undocumented populations and a risk adjustment update [38][39] Question: Adjustments to benefit design in Medicaid - Management noted some sporadic adjustments to benefit design but emphasized that there is no wholesale shift occurring [48] Question: Membership attrition assumptions for 2026 - Management projected a 2% membership attrition, believing that the effects of redetermination are largely over [51][54] Question: Size of Medicaid expansion enrollment and attrition sources - The Medicaid expansion population is about 1.3 million members, with expected attrition of 15%-20% due to new policies [59][60] Question: Potential negative dynamics affecting 2026 guidance - Management acknowledged that while there are potential upside components, they believe rates at 4% are a floor, with no significant downside expected [64]